Physician profile

Ryan Zerr

Sports Medicine (Family Medicine) · Yuma, AZ

NPI 1093988578

$262.33

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$37.11

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sunovion Pharmaceuticals INC. $80.14 2019
Amgen INC. $42.27 2019
Novo Nordisk INC $33.37 2019
Janssen Pharmaceuticals, INC $22.79 2019
Orthofix Medical, INC. $18.79 2023 Physio-Stim
Ossur Americas, INC. $18.32 2024 Miami J
Allergan, INC. $13.05 2019
Sanofi-Aventis U.S. LLC $11.52 2019
Ferring Pharmaceuticals INC. $11.36 2019
Dynasplint Systems INC. $10.72 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ryan Zerr

$262.33

in general payments reported 2019-2025

Years
2019-2024
Top company
Sunovion Pharmaceuticals INC.

https://glasscript.com/doctor/992754/ryan-zerr

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.